HopeStage
Back to all studies
CompletedNCT04022577

Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder

Official study title

Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder: A Randomized Controlled Trial

Behavioural studyAges 20–64Taiwan
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 20 years to 64 years. Other eligibility criteria applied.

Listed locations
Taipei, TaiwanSee all locations and recruitment
Activities
Behavioural activities described in the protocol · Placebo comparator
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: October 1, 2018
Recruitment status
Completed
Enrollment listed in the registry
120
Sponsor
National Yang Ming Chiao Tung University
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Taiwan
Age range
From 20 Years to 64 Years
Official registry ID
NCT04022577

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Taipei

FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Yang Ming Chiao Tung University, a university.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 20 years to 64 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me